Results 211 to 220 of about 160,832 (337)

Drug‐releasing intravesical floating technology for sequential gemcitabine and docetaxel in non‐muscle‐invasive bladder cancer

BJU International, EarlyView.
Objectives To develop a drug‐releasing intravesical floating technology (DRIFT) device for controlled sequential delivery of gemcitabine and docetaxel (Gem/Doce) to optimise the treatment of non‐muscle‐invasive bladder cancer (NMIBC) while enabling patient mobility and self‐removal, as sequential intravesical Gem/Doce has been increasingly utilised but
Ashley C. Rhodes, Kaitlyn A. McClintic, Emily Witt, Ikenna Nwosu, Kyle R. Balk, Colin Reis, Ian C. Sutton, Jianling Bi, Melinda Z. Fu, Michael A. O’Donnell, Vignesh T. Packiam, James D. Byrne   +11 more
wiley   +1 more source

Icotinib plus gemcitabine for metastatic pancreatic cancer: A case report

, 2015
Jing Zhao, Hong Shen, Hanguang Hu, Jianjin Huang   +3 more
openalex   +2 more sources

Risk of metachronous upper tract urothelial carcinoma following non‐muscle‐invasive bladder cancer

BJU International, EarlyView.
Objective To determine the risk and timing of metachronous upper tract urothelial carcinoma (UTUC) after non‐muscle‐invasive bladder cancer (NMIBC). Patients and Methods In this multi‐institutional retrospective cohort study involving academic and community hospitals, clinicopathological data were collected from patients with NMIBC treated between 2005
Keiran J.C. Pace, Jethro C.C. Kwong, Harkanwal Randhawa, Maximiliano Ringa, Zizo Al‐Daqqaq, Yashan Chelliahpillai, Soomin Lee, Kellie Kim, Samuel Haile, Amna Ali, Marian Wettstein, Amy Chan, Nathan Perlis, Jason Lee, Robert Hamilton, Neil Fleshner, Antonio Finelli, Munir Jamal, Frank Papanikolaou, Thomas Short, Andrew Feifer, Girish Kulkarni, Alexandre R. Zlotta   +22 more
wiley   +1 more source

Gemcitabine-Induced Thrombotic Microangiopathy in a Patient With Metastatic Pancreatic Cancer: A Case Report. [PDF]

Cureus
Young J.
europepmc   +1 more source

Carbonic Anhydrase 12 as a Novel Prognostic Biomarker and Therapeutic Target for High‐Risk Follicular Thyroid Carcinoma

Cancer Science, EarlyView.
In this study, we identified a novel biomarker, carbonic anhydrase 12 (CA12), to better distinguish high‐risk follicular thyroid carcinoma (FTC). High CA12 expression is associated with poor prognosis and CA12 promotes tumor cell growth and invasion. This study suggests that CA12 is not only an independent predictor of disease‐free survival but also a ...
Masashi Tanida, Tsuyoshi Takashima, Shinichiro Tahara, Masaharu Kohara, Haruka Kanai, Masami Suzuki, Motoyuki Suzuki, Mitsuyoshi Hirokawa, Ayana Suzuki, Shinya Sato, Daisuke Okuzaki, Satoshi Nojima, Takahiro Matsui, Hidenori Inohara, Eiichi Morii   +14 more
wiley   +1 more source

Organochloride mediated prodrug activation induced by ionizing radiation. [PDF]

Chem Sci
Liu J, Xu B, de Geus MAR, Denkova AG, Eelkema R.   +4 more
europepmc   +1 more source

The Efficacy and Toxicity of Adjuvant Gemcitabine-Cisplatin Chemotherapy in Patients with Advanced Bladder Cancer Underwent Radical Cystectomy

, 2010
Tansu Değirmenci, Bülent Günlüsoy, Murat Arslan, Enver Vardar, Zafer Kozacıoğlu, Süleyman Minareci, Riza Ayder   +6 more
openalex   +1 more source

Gemcitabine-based therapy in pancreas cancer [PDF]

, 2002
Andrew Jacobs
openalex   +1 more source

Targeting Genome Maintenance Defects of Cancers Using Chain‐Terminating Nucleoside Analogs

Cancer Science, EarlyView.
Nucleoside analogs interfere with DNA replication either by their chain‐terminating properties or by serving as DNA damage on the template. The genome maintenance pathways required to maintain cellular tolerance to each nucleoside analog vary depending on the drug.
Ryotaro Kawasumi, Rubaiat E. Tabassum, Kouji Hirota   +2 more
wiley   +1 more source

PLK1 inhibition enhances gemcitabine-induced apoptosis through PLK1-dependent ERK1/2-Bim and AKT1/Noxa signals in pancreatic cancer cells. [PDF]

Med Oncol
Lu B, Li H, Deng D, Wang Y.
europepmc   +1 more source